FolioLanternBeta
CAICaris Life Sciences, Inc.

John Denton

Senior Vice President, General Counsel, and Secretary at Caris Life Sciences, Inc., as of Sep 23, 2026Sold $239K of stock in the past 12 months: 100% with no plan disclosed. Bought $101K of stock in 1 open-market purchase.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
7.5K
shares sold, past 12 months
1
days with sales
$239K
largest single day, Sep 22, 2026
$101K
open-market purchases, past 12 months (1 trade)
1
company filed for

Share of stake sold and shares held at Caris Life Sciences, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAugSep 2026: $239K no plan disclosed$239KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Caris Life Sciences, Inc. (CAI)Senior Vice President, General Counsel, and SecretaryJun 17, 2025Sep 23, 2026

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.